U.S. prices of Revlimid compared to prices in select countries 2020
In 2020, both the estimated U.S. net price and gross price for a one-month supply (28 capsules) of Revlimid Oral Capsule (10mg) were over four times higher than gross prices paid in Australia. In comparison, while less extreme, U.S. prices of Revlimid were still over 2.5 times higher than Canadian.
Revlimid is an immunomodulatory drug used to treat Multiple Myeloma (blood cancer) or anemia in patients with myelodysplastic syndrome.
This statistic shows Revlimid's net and gross prices in the United States compared to gross prices in Australia and Canada as of 2020.